Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
Price Target
Average
162.78%
Revenue Forecast
Estimate
60.98%
EBIT
Estimate
--42.66%
Net Income
Estimate
35.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ultragenyx Pharmaceutical Inc.
Wall Street analysts predict an average 1-year price target for RARE of $105 , with forecasts ranging from
a
low of
$67 to a high of $135 .
RARE Lowest Price Target
Wall Street Target
67 USD
67.50%
RARE Average Price Target
Wall Street Target
105 USD
162.78%
RARE Highest Price Target
Wall Street Target
135 USD
237.50%
REVENUE FORECAST
Revenue Forecast Chart RARE
EBIT FORECAST
EBIT Forecast Chart RARE
NET INCOME FORECAST
Net Income Chart RARE